Italian BiodivYsio open registry (BiodivYsio PC-coated stent): Study of clinical outcomes of the implant of a PC-coated coronary stent

Journal of Invasive Cardiology

Volumn 12, Issue 9, 2000, Pages 452-458

  Galli, Mario ^a   Bartorelli, Antonio ^b   Bedogni, Francesco ^c   DeCesare, Nicoletta ^d   Klugmann, Silvio ^e   Maiello, Luigi ^c   Miccoli, Florenzo ^f   Moccetti, Tiziano ^g   Onofri, Marco ^c   Paolillo, Vito ^h   Pirisi, Raimondo ⁱ   Presbitero, Patrizia ^c   Sganzerla, Paolo ^c   Viecca, Maurizio ^c   Zerboni, S ^a   Lanteri, Giorgio ^c  

^a SANT ANNA HOSPITAL   (Italy)

^b CENTRO CARDIOLOGICO MONZINO   (Italy)

^c Ist Clinico S Ambrogio Milano ^*  (Italy)

^d IRCCS MULTIMEDICA   (Italy)

^e OSPEDALE NIGUARDA CA GRANDA   (Italy)

^f UNIVERSITY OF GENOA   (Italy)

^g Ospedale Civico Lugano   (Switzerland)

^h S GIOVANNI BOSCO HOSPITAL   (Italy)

ⁱ Ospedale S Giovanni Cagliari   (Italy)

Author keywords

Major adverse cardiac events; Percutaneous transluminal coronary angioplasty

Indexed keywords

BIOMATERIAL; PHOSPHORYLCHOLINE; POLYMER;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; INSTRUMENTATION; ITALY; MALE; MIDDLE AGED; MULTICENTER STUDY; PROSTHESIS; RADIOGRAPHY; SAFETY; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PHOSPHORYLCHOLINE; POLYMERS; PROSTHESIS DESIGN; SAFETY; STENTS;

EID: 0034265760     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Pepine CJ, Holmes DR. ACC expert consensus document coronary artery stents. J Am Coll Cardiol 1996;28:782-794.
2. Fischman DL, Leon MB, Baim DS, et al. for the Stent Restenosis Study Investigators. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501.
3. Alfonso F, Rodriguez P, Phillips P, et al. Clinical and angiographic implications of coronary stenting in thrombus-containing lesions. J Am Coll Cardiol 1997;29:725-733.
4. Stone WG, Brodie BR, Griffin JJ, et al. Prospective, multi-center study of the safety and feasibility of primary stenting in acute myocardial infarction: In-hospital and 30-day results of the PAMI stent pilot trial. J Am Coll Cardiol 1998;31:23-30.
5. Stone WG, Brodie BR, Griffin JJ, et al. Clinical and angiographic follow-up after primary stenting in acute myocardial infarction. Circulation 1999;99:1548-1554.
6. Società di Cardiologia Interventistica-GISE: 1998 Italian laboratory activity data.
7. Harker LA, Kelly AB, Hanson SR, et al. Reduction in thrombus formation by placement of endovascular stents at endarterectomy sites in baboon carotid arteries. Circulation 1991;84(Suppl IV):IV-41-IV-55.
8. Chronos NAF, Robinson KA, Kelly AB, et al. Thrombo-resistant phosphorylcholine coating for coronary stents Circulation 1995;92(Suppl I):I-685.
9. Ellis SG, Vandormael MG, Cowley MJ, et al. Coronary morphological and clinical determinants of procedural outcome with angioplasty for multivessel disease. Circulation 1990;82:1193-1202.
10. Moussa I, Di Mario C, Reimers B, et al. Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: Frequency, predictors and clinical outcome. J Am Coll Cardiol 1997;29:6-12.
11. George BS, Voorhees WD, Roubin GS, et al. Multi-center investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: Clinical and angiographic outcomes. J Am Coll Cardiol 1993;22:135-143.
12. Roubin GS, Cannon AD, Agrawal SK, et al. Intracoronary stenting for acute or threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation 1992;85:916-927.
13. Sigwart U, Urban P, Golf S, et al. Emergency stenting for acute occlusion after coronary balloon angioplasty. Circulation 1998;78:1021-1027.
14. Malosky SA, Hirshfeld JW, Herrmann HC. Comparison of results of intracoronary stenting in patients with unstable vs. stable angina. Cathet Cardiovasc Diagn 1994;31:95-101.
15. Theroux P. Angiographic and clinical progression in unstable angina. From clinical observation to clinical trials. Circulation 1995;91:2295-2298.
16. Rizik DG, Healy S, Margulis A, et al. A new clinical classification for hospital prognosis of unstable angina pectoris. J Am Coll Cardiol 1995;75:675-682.
17. Schulhlen H, Hadamitsky M, Walter H, et al. Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement. Circulation 1997;95:2015-2021.
18. Leon MB, Baim DS, Popma JJ, et al. A clinical trial comparing three antithrombotic drug regimens after coronary stenting. N Engl J Med 1998;339:1665-1671.
19. Grassman ED, Leye F, Johnson SA, et al. Percutaneous transluminal coronary angiography for unstable angina: Predictors of outcome in a multi-center study. J Thromb Thrombol 1994;1:73-78.
20. De Servi S, Repetto S, Bossi I, et al. Predictors of major in-hospital ischemic complications and length of hospital stay after coronary stenting. G Ital Cardiol 1998;28:1345-1353.
21. Serruys PW, De Jaegere P, Kiemeneij F, et al. for the BENESTENT study group. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-495.
22. Gertoge CS, Baim DS, Brinker JA, et al. One-year follow-up of the stent restenosis (STRESS I) study. Am J Cardiol 1998;81:860-865.
23. Galli M, Zerboni S, Politi A, et al. Short- and mid-term clinical results with BiodivYsio stent, a PC-coated stent, in primary coronary stenting for acute myocardial infarction. Am J Cardiol 1999;86(Suppl 6A):110P.
24. Poland JL, Corbeij HAM, Seabra Gomes R, et al. For the SOPHOS Study Investigators. (Abstr). European Society of Cardiology-Barcelona, Spain 1999.
25. Zheng H, Barragan P, Corcos T, et al. Clinical experience with a new biocompatible phosphorylcholine-coated coronary stent. J Invas Cardiol 1999;11:608-614.
26. Park SJ, Park SW, Lee CW, et al. Immediate results and late clinical outcomes after new CrossFlex coronary stent implantation. J Am Coll Cardiol 1999;83:502-506.
27. Baim DS, Cutlip DE, Midei M, et al. Acute 30-day and late clinical events in the randomized parallel group comparison of the ACS Multi-Link coronary stent system and the Palmaz-Schatz stent (Abstr). Circulation 1997;18:I-593.
28. Hauser RR, Kuntz RE, Lansky AJ, et al. The SMART trial: Acute outcome indicates superior efficacy with the AVE stent (Abstr). Circulation 1997;18:I-593.
29. Dirschinger J, Schulen H, Boekstegers P, et al. Equivalence or difference? One-year follow-up of a randomized trial of five different slotted-tube stents. Circulation 1998;98:171-661.
30. Gunn J, Cumberland D. Stents coatings and local drug delivery. Eur Heart J 1999;20:1693-1700.